NCT06202599 2024-01-17Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' ResistancePeking University People's HospitalCompleted124 enrolled
NCT06031376 2023-09-11Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRCHunan Cancer HospitalCompleted106 enrolled